Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Kaposi, HIV Infections, Carcinoma, Medullary, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03520660 2026-03-11

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

121 enrolled

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT03028311 2026-03-10

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

Phase 1 Active not recruiting

12 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06859840 2026-03-10

LEAF

Phase NA Active not recruiting

10,000 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT06938945 2026-03-10

Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial

Phase NA Active not recruiting

500 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT06084884 2026-03-09

ATHENA

Phase 1/2 Active not recruiting

94 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03264664 2026-03-06

Study of E7386 in Participants With Selected Advanced Neoplasms

Phase 1 Active not recruiting

60 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT03847428 2026-03-06

EMERALD-2

Phase 3 Active not recruiting

908 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06018857 2026-03-06

Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation

Active not recruiting

1,000 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04563338 2026-03-05

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Phase 2 Active not recruiting

36 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04721132 2026-03-05

Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer

Phase 2 Active not recruiting

16 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT05953337 2026-03-04

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Phase NA Active not recruiting

120 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT07444905 2026-03-03

Evaluation of a Machine Learning-Based Prediction Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

Active not recruiting

800 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT05063565 2026-03-02

ROWAN

Phase 2 Active not recruiting

100 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT03833700 2026-02-27

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Phase 1 Active not recruiting

70 enrolled

EndocrineGastrointestinalNETSarcoma

Gastro-enteropancreatic neuroendocrine tumor, Digestive System Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Desmoid Tumors, Adrenocortical Carcinoma

NCT04008797 2026-02-27

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Phase 1/2 Active not recruiting

301 enrolled

GastrointestinalGynecologic

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07437859 2026-02-27

Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment

Active not recruiting

60 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04039607 2026-02-19

CheckMate 9DW

Phase 3 Active not recruiting

732 enrolled 1 FDA

Gastrointestinal

Carcinoma, Hepatocellular

Clinical Trials

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

EMERALD-Y90

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

LEAF

Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial

ATHENA

Study of E7386 in Participants With Selected Advanced Neoplasms

EMERALD-2

Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Evaluation of a Machine Learning-Based Prediction Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

ROWAN

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment

CheckMate 9DW